Head of The Research Centre of Altitude Medicine from The School of Medicine at The Universidad de San Martín de Porres. Head of The Research Centre of Traditional Medicine and Pharmacology in The School of Medicine at The Universidad de San Martín de Porres. General Physichian, Doctor of Medicine, Master in Pharmacology, Posdtoc in Clinical Research from The School of Medicine at The Universidade de Sao Paulo, Postdoc in Hypertension and Pharmacogenetic from The School of Medicine at The Universidade de Sao Paulo, Postdoc in Teratology and herbal Medicines from Teratology Information System (SIAT Gravides Segura) at Universidade Federal de Rio Grande do Sul. Peruvian Society of Experimental Pharmacolgy and Therapeutics (SOPFARTEX). Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF).
Dr. Shihui Guo is a Research Fellow at Beth Israel Deaconess Medical Center/Harvard Medical School, specializing in the redox regulation of thrombosis. With a PhD in Molecular Biology from the University of Salzburg, his research investigates the critical role of thiol isomerases, notably, platelet PDI and vascular ERp46, in platelet function, coagulation, and thrombus formation within the context of ER stress. Dr. Guo has published more than 15 papers in high-impact journals, contributing to our understanding of vascular signaling and its impact on thrombotic disorders. He actively collaborates on novel anticoagulant strategies and serves as a journal reviewer, bringing expertise in molecular and cell biology, thrombosis research, and the interplay between endothelial function and platelet biology. His work bridges the gap between basic science and clinical application, with a strong focus on translating findings into improved patient outcomes.
Moua Yang received his Ph.D. in Cell Biology from the Medical College of Wisconsin, where his training was performed at the Blood Research Institute of Versiti Blood Center of Wisconsin. His Ph.D. was in the field of platelet redox signaling in arterial thrombosis as it relates to dyslipidemia. He then pursued postdoctoral training at the Medical College of Wisconsin, where he focused on the biochemistry of oxidative cysteine modification. He furthered his postdoctoral training at Beth Israel Deaconess Medical Center and Harvard Medical School, where he investigated the role of thiol isomerases in thrombosis and hemostasis. Additionally, he focused on understanding the dynamics of in vivo thrombus formation in murine models using intravital microscopy. Dr. Yang is currently an Assistant Member at Bloodworks Northwest Research Institute and Assistant Professor at the University of Washington School of Medicine. He has co-authored a number of peer-reviewed articles and has presented his work numerous times at national conferences. His research topics mainly include thrombosis, hemostasis, redox biology, oxidative cysteine modification, and disulfide biology.
